首页> 外国专利> CHROMANE SYSTEM DERIVATIVE AND A PHARMACEUTICAL COMPOSITION INCLUDING THEREOF FOR PREVENTING MULTIPLE MYELOMA, RHEUMATOID ARTHRITIS AND CANCER

CHROMANE SYSTEM DERIVATIVE AND A PHARMACEUTICAL COMPOSITION INCLUDING THEREOF FOR PREVENTING MULTIPLE MYELOMA, RHEUMATOID ARTHRITIS AND CANCER

机译:防止多发性骨髓瘤,类风湿关节炎和癌症的氯气系统衍生物和包括其的药物成分

摘要

PURPOSE: A chromane system derivative and a pharmaceutical composition including thereof are provided to control the nuclear factor kappaB which is an essential transcription factor controlling various genes for preventing multiple myeloma, rheumatoid arthritis and cancer.;CONSTITUTION: A chromane system derivative is marked as the chemical formula 1. In the chemical formula 1, R1 to R4 refer to hydrogen, hydroxy, alkoxy with the carbon number of 1~8, alkyl with the carbon number of 1~8, trifluoroalkyl with the carbon number of 1~4, halogen or nitro radical, respectively. A pharmaceutical composition contains the chromane system derivative or allowable salt of the chromane system derivative as an active ingredient. The pharmaceutical composition contains 0.001~99.9wt% of chromane system derivative.;COPYRIGHT KIPO 2010
机译:目的:提供一种色烷系统衍生物及其药物组合物,以控制核因子κB,该因子是控制多种基因的必需转录因子,可预防多发性骨髓瘤,类风湿性关节炎和癌症。化学式1在化学式1中,R 1至R 4表示氢,羟基,碳数为1〜8的烷氧基,烷基的碳数为1〜8,三氟烷基的碳数为1〜4,卤素或硝基。药物组合物包含苯并二氢吡喃酮系衍生物或苯并二氢吡喃酮系衍生物的容许盐作为有效成分。该药物组合物包含0.001〜99.9wt%的苯甲醚系衍生物。; COPYRIGHT KIPO 2010

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号